Bio-Rad Laboratories IncClass A
 
 
 
 
公司概覽
業務類別 Medical Devices
業務概覽 Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
公司地址 1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
電話號碼 +1 510 724-7000
傳真號碼 +1 510 741-5817
公司網頁 https://www.bio-rad.com
員工數量 7450
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Roop K. Lakkaraju Principal Accounting Officer, Executive Vice President and Chief Financial Officer 美元 426.92K 13/02/2026
Mr. James J. Barry Executive Vice President and President, Life Science Group -- 26/03/2025
Ms. Colleen Corey Executive Vice President, Global Human Resources -- 26/03/2025
Mr. Norman Schwartz Chairman of the Board and Chief Executive Officer 美元 1.06M 13/02/2026
Mr. Jonathan P. DiVincenzo President and Chief Operating Officer 美元 204.52K 26/03/2025
Mr. Rajat Mehta Executive Vice President, Global Commercial Operations -- 28/07/2025
Mr. Sedat Evran Executive Vice President, Global Supply Chain -- 26/03/2025
Ms. Courtney Camp Enloe Executive Vice President, General Counsel and Secretary -- 26/03/2025
Ms. Eva Anette Engelhardt Executive Vice President and President, Clinical Diagnostics Group 美元 292.79K 26/03/2025
Ms. Allison Schwartz Director and Vice President, Global Supply Chain Clinical Diagnostics Group Operations -- 13/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Arnold A. Pinkston Independent Director 13/02/2026
Mr. Gregory K. Hinckley Lead Independent Director 13/02/2026
Mr. Jeffrey L. Edwards Independent Director 13/02/2026
Mr. Norman Schwartz Chairman of the Board and Chief Executive Officer 13/02/2026
Ms. Melinda Litherland Independent Director 13/02/2026
Ms. Allison Schwartz Director and Vice President, Global Supply Chain Clinical Diagnostics Group Operations 13/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:36)
代號 名稱 佔比% 持有日期
DXUVDimensional US Vector Equity ETF0.001%27/02/2026
MIDUDirexion Daily Mid Cap Bull 3X ETF0.001%26/02/2026
CVLCCalvert US Large-Cp Cor Rspnb ETF0.001%27/02/2026
GVUSGoldman Sachs MktBt Russell LgCpValEqETF0.001%27/02/2026
HELXFranklin Genomic Advancements ETF0.001%28/02/2026
EPSBHarbor SMID Cap Core ETF0.001%28/02/2026
JUSTGoldman Sachs JUST US Large Cap Eq ETF0.001%27/02/2026
EPMBHarbor Mid Cap Core ETF0.001%28/02/2026
CVMCCalvert US Mid-Cp Cor Rspnb ETF0.001%27/02/2026
MDEVFirst Trust Indxx Global Mdcl Dvcs ETF0.0005%26/02/2026
AVSUAvantis Responsible US Equity ETF0.0005%28/02/2026
UMDDProShares UltraPro MidCap4000.0004%27/02/2026
PEXLPacer US Export Leaders ETF0.0003%27/02/2026
AVTMAvantis Total Equity Markets ETF0.0002%28/02/2026
DEUSXtrackers Russell US Multifactor ETF0.0002%26/02/2026
MIDEXtrackers S&P MidCap 400 Scrd & Scrn ETF0.0001%26/02/2026
TNXTT. Rowe Price Innovation Leaders ETF0.0001%28/02/2026
ONEOStt Strt® SPDR® Russell 1000 Momt FocETF0.0001%27/02/2026
CDEICalvert US Large-Cp Div, Eq AndIncETF0.00002%27/02/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.00001%27/02/2026
  1    2    3    4   5    6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.